• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于不同影像学亚型的原发性肺黏液腺癌的临床病理特征和生存结局。

Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.

机构信息

Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.

Clinical Research Center, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China.

出版信息

Ann Surg Oncol. 2024 Jan;31(1):167-177. doi: 10.1245/s10434-023-14193-w. Epub 2023 Nov 5.

DOI:10.1245/s10434-023-14193-w
PMID:37925652
Abstract

BACKGROUND

Primary lung mucinous adenocarcinomas (LMAs) could be subclassified as the pure-solid, part-solid, and pneumonic types according to the findings of high-resolution computed tomography. This study aimed to expound on the clinicopathologic, radiologic, and prognostic characteristics of LMAs based on radiologic classification within a large set of patients.

METHODS

From November 2009 to December 2016, this study enrolled 294 resected LMAs, which were divided into the pure-solid (n = 169), part-solid (n = 87), and pneumonic (n = 38) types. The clinicopathologic and radiologic characteristics of the tumors were evaluated, and patient prognosis was determined through follow-up evaluation. Survival outcomes were calculated by Kaplan-Meier curves and compared using log-rank tests. The prognostic impact of clinicopathologic variables, including radiologic presentations, were evaluated by establishing a Cox proportional hazards model.

RESULTS

The LMAs were infrequently associated with lymph node metastasis (5.4 %), lymphatic/vascular invasion (4.4 %), or visceral pleural invasion (5.1 %). During the median 71-month follow-up period, recurrence was observed in 62 patients and death in 44 patients. The patients with pneumonic-type LMAs had a poorer prognosis (5-year recurrence-free survival [RFS], 23.7 %; 5-year overall survival [OS], 44.7 %) than those with the pure-solid type (RFS, 83.2 %; OS, 100 %) or part-solid type (RFS, 93.7 %; OS, 100 %). Besides, lymph node metastasis, emphysema, and clinical T stage were independent predictors of RFS and OS.

CONCLUSION

Solitary-type LMA patients had excellent prognoses, whereas the survival outcomes for pneumonic-type LMA patients were dismal. Furthermore, pneumonic-type LMA patients were prone to intrapulmonary metastasis by means of aerogenous dissemination rather than distant metastasis.

摘要

背景

根据高分辨率计算机断层扫描的结果,原发性肺黏液腺癌(LMAs)可细分为纯实性、部分实性和肺炎型。本研究旨在阐述基于影像学分类的大量患者中 LMAs 的临床病理、影像学和预后特征。

方法

本研究纳入了 2009 年 11 月至 2016 年 12 月期间切除的 294 例 LMAs,分为纯实性(n = 169)、部分实性(n = 87)和肺炎型(n = 38)。评估肿瘤的临床病理和影像学特征,并通过随访评估患者的预后。生存结果通过 Kaplan-Meier 曲线计算,并通过对数秩检验进行比较。通过建立 Cox 比例风险模型评估包括影像学表现在内的临床病理变量的预后影响。

结果

LMAs 淋巴结转移(5.4%)、淋巴管/血管侵犯(4.4%)或内脏胸膜侵犯(5.1%)的发生率较低。在中位 71 个月的随访期间,62 例患者出现复发,44 例患者死亡。肺炎型 LMA 患者的预后较差(5 年无复发生存率 [RFS],23.7%;5 年总生存率 [OS],44.7%),低于纯实性型(RFS,83.2%;OS,100%)或部分实性型(RFS,93.7%;OS,100%)。此外,淋巴结转移、肺气肿和临床 T 分期是 RFS 和 OS 的独立预测因素。

结论

孤立型 LMA 患者的预后良好,而肺炎型 LMA 患者的生存结果较差。此外,肺炎型 LMA 患者更容易通过空气传播发生肺内转移,而不是远处转移。

相似文献

1
Clinicopathologic Features and Survival Outcomes of Primary Lung Mucinous Adenocarcinoma Based on Different Radiologic Subtypes.基于不同影像学亚型的原发性肺黏液腺癌的临床病理特征和生存结局。
Ann Surg Oncol. 2024 Jan;31(1):167-177. doi: 10.1245/s10434-023-14193-w. Epub 2023 Nov 5.
2
Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings.基于 CT 表现比较原发性肺浸润性黏液腺癌的临床病理特征和预后。
Cancer Imaging. 2019 Jul 10;19(1):47. doi: 10.1186/s40644-019-0236-2.
3
Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?单肺叶肺炎型侵袭性黏液性腺癌 CT 表现的预后:将其定义为临床 T3 是否合理?
Korean J Radiol. 2022 Mar;23(3):370-380. doi: 10.3348/kjr.2021.0465.
4
Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.原发性肺黏液腺癌:CT影像特征联合临床因素的预后价值
Korean J Radiol. 2021 Apr;22(4):652-662. doi: 10.3348/kjr.2020.0454. Epub 2020 Nov 19.
5
Radiological and clinical features of large consolidative-type pulmonary invasive mucinous adenocarcinoma.大实变型肺侵袭性黏液性腺癌的放射学及临床特征。
Clin Respir J. 2024 Mar;18(3):e13743. doi: 10.1111/crj.13743.
6
[Construction of a Prognostic Prediction Model of Patients with Pathologic N0 
in Resected Invasive Mucinous Adenocarcinoma of the Lung].[肺浸润性黏液腺癌切除术后病理N0患者预后预测模型的构建]
Zhongguo Fei Ai Za Zhi. 2024 Jan 20;27(1):47-55. doi: 10.3779/j.issn.1009-3419.2024.106.02.
7
The prognostic value of Kirsten rat sarcoma viral oncogene homolog mutations in resected lung adenocarcinoma differs according to clinical features.KRAS 基因突变在肺腺癌中的预后价值因其临床特征而异。
J Thorac Cardiovasc Surg. 2022 Jan;163(1):e73-e85. doi: 10.1016/j.jtcvs.2020.05.097. Epub 2020 Jun 21.
8
Radiologic Predictors for Clinical Stage IA Lung Adenocarcinoma with Ground Glass Components: A Multi-Center Study of Long-Term Outcomes.具有磨玻璃成分的临床IA期肺腺癌的放射学预测因素:一项长期预后的多中心研究
PLoS One. 2015 Sep 4;10(9):e0136616. doi: 10.1371/journal.pone.0136616. eCollection 2015.
9
Clinical T1aN0M0 lung cancer: differences in clinicopathological patterns and oncological outcomes based on the findings on high-resolution computed tomography.高分辨率 CT 检查结果对 T1aN0M0 期肺癌临床病理模式和肿瘤学结局的影响
Eur Radiol. 2021 Oct;31(10):7353-7362. doi: 10.1007/s00330-021-07865-2. Epub 2021 Apr 15.
10
Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea.韩国 TKI 时代的外科数据库研究:与 IASLC 浸润性非黏液性腺癌组织学分级系统相比,切除的浸润性黏液性腺癌的预后。
Thorac Cancer. 2022 Dec;13(23):3310-3321. doi: 10.1111/1759-7714.14687. Epub 2022 Nov 7.

引用本文的文献

1
Sublobectomy versus lobectomy for peripheral small-sized pulmonary mucinous adenocarcinoma.肺叶下切除术与肺叶切除术治疗周围型小尺寸肺黏液腺癌的对比
J Thorac Dis. 2025 Jan 24;17(1):390-399. doi: 10.21037/jtd-2024-2096. Epub 2025 Jan 22.
2
Pulmonary mucinous adenocarcinoma: An overview of pathophysiology and advancements in treatment.肺黏液腺癌:病理生理学概述与治疗进展
Heliyon. 2024 Mar 29;10(9):e28881. doi: 10.1016/j.heliyon.2024.e28881. eCollection 2024 May 15.

本文引用的文献

1
Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.侵袭性黏液性与非黏液性肺腺癌的手术结局比较。
Ann Thorac Surg. 2021 Oct;112(4):1118-1126. doi: 10.1016/j.athoracsur.2020.09.042. Epub 2020 Nov 24.
2
Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors.原发性肺黏液腺癌:CT影像特征联合临床因素的预后价值
Korean J Radiol. 2021 Apr;22(4):652-662. doi: 10.3348/kjr.2020.0454. Epub 2020 Nov 19.
3
Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study.
浸润性黏液腺癌对手术切除后肺癌特异性生存的影响:一项基于人群的研究。
J Thorac Dis. 2018 Jun;10(6):3595-3608. doi: 10.21037/jtd.2018.06.09.
4
Biology of invasive mucinous adenocarcinoma of the lung.肺侵袭性黏液腺癌的生物学
Transl Lung Cancer Res. 2017 Oct;6(5):508-512. doi: 10.21037/tlcr.2017.06.10.
5
Pulmonary invasive mucinous adenocarcinoma and mixed invasive mucinous/nonmucinous adenocarcinoma-a clinicopathological and molecular genetic study with survival analysis.肺浸润性黏液性腺癌及混合性浸润性黏液/非黏液性腺癌——一项临床病理和分子遗传学研究并结合生存分析。
Hum Pathol. 2018 Jan;71:8-19. doi: 10.1016/j.humpath.2017.08.002. Epub 2017 Aug 17.
6
Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings.基于计算机断层扫描结果的肺浸润性黏液腺癌的临床病理及免疫组化特征
Onco Targets Ther. 2016 Dec 28;10:153-163. doi: 10.2147/OTT.S121059. eCollection 2017.
7
Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.IV期肺浸润性黏液腺癌的临床病程
Lung Cancer. 2016 Dec;102:82-88. doi: 10.1016/j.lungcan.2016.11.004. Epub 2016 Nov 6.
8
Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.肺浸润性黏液腺癌的预后:相关因素及与肺非黏液腺癌的比较。
J Thorac Oncol. 2016 Jul;11(7):1064-73. doi: 10.1016/j.jtho.2016.03.011. Epub 2016 Mar 22.
9
Pulmonary mucinous adenocarcinomas: architectural patterns in correlation with genetic changes, prognosis and survival.肺黏液腺癌:与基因改变、预后和生存相关的组织学模式
Virchows Arch. 2015 Dec;467(6):675-686. doi: 10.1007/s00428-015-1852-2. Epub 2015 Oct 8.
10
Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.肺浸润性黏液腺癌的独特遗传和生存特征。
J Thorac Oncol. 2015 Aug;10(8):1156-62. doi: 10.1097/JTO.0000000000000579.